Adverse outcome pathways: Hype or hope?

Archives of Toxicology

Volumn 88, Issue 1, 2014, Pages 1-2

  Vinken, Mathieu ^a   Whelan, Maurice ^b   Rogiers, Vera ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENOL; ANILINE DERIVATIVE; CHEMICAL COMPOUND;

ADVERSE OUTCOME; BIOLOGY; CHEMICAL STRUCTURE; CONCEPTUAL FRAMEWORK; ECOTOXICOLOGY; EDITORIAL; ENVIRONMENT; HEALTH; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PHOTOTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SCREENING TEST; SKIN SENSITIZATION; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ECOTOXICOLOGY; HUMANS; TOXICITY TESTS;

EID: 84892624109     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-013-1093-6     Document Type: Editorial

References (14)

1. Andersen ME, Clewell R, Bhattacharya S (2012) Developing in vitro tools sufficient by themselves for 21st century risk assessment. In: Gocht T, Schwarz M (eds) Towards the replacement of in vivo repeated dose systemic toxicity testing, vol 2. Imprimerie Mouzet, France, pp 347-360
2. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730-741
3. EU (2003) Directive 2003/15/EC of the European parliament, of the council of 27 February amending council directive 76/768/EEC on the approximation of the laws of the member states relating to cosmetic products. OV J L 066:26-35
4. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295-300
5. Jennings P (2013) Stress response pathways, toxicity pathways and adverse outcome pathways. Arch Toxicol 87:13-14
6. Landesmann B, Goumenou M, Munn S, Whelan M (2012) Description of prototype modes-of-action related to repeated dose toxicity. JRC Scientific and Policy Report 75689
7. NRC (2007) Toxicity testing in the 21st century: a vision and a strategy. The National Academies Press, Washington, DC
8. OECD (2011) Report of the workshop on using mechanistic information on forming chemical categories. Series on testing and assessment No. 138
9. OECD (2012a) Proposal for a template and guidance on developing and assessing the completeness of adverse outcome pathways
10. OECD (2012b) The adverse outcome pathway for skin sensitization initiated by covalent binding to proteins part I: scientific evidence. Series on testing and assessment No. 168
11. Pauwels M, Rogiers V (2010) Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science. Toxicol Appl Pharmacol 243:260-274
12. US EPA (2005) Guidelines for carcinogen risk assessment. Washington, DC
13. Vinken M, Pauwels M, Ates G, Vivier M, Vanhaecke T, Rogiers V (2012) Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients. Arch Toxicol 86:405-412
14. Vinken M, Landesmann B, Goumenou M, Vinken S, Shah I, Jaeschke H, Willett C, Whelan M, Rogiers V (2013) Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci (submitted)